Literature DB >> 1500737

Meningococcal disease and influenza-like syndrome: a new approach to an old question.

B Hubert1, L Watier, P Garnerin, S Richardson.   

Abstract

The temporal and spatial association of meningococcal disease and influenza-like syndrome (ILS) was assessed from surveillance data on these diseases in France for a 6-year period (1985-1990). Using time series methods to account for the usual seasonal pattern meningococcal disease, the incidence of meningococcal disease in a given week was found to be linked to incidence of ILS in the 5 previous weeks but not to that in subsequent weeks. Geographic spread of meningococcal disease correlated with spread of ILS. This study also suggests that meningococcal disease is more severe for a 2-month period during and after an ILS epidemic: The proportion of cases with purpura fulminans increased by 24% and those resulting in death by 26% during this period. No shift in the age distribution was observed. When an ILS epidemic is identified, medical practitioners should be informed of the likelihood of an increased incidence and severity of meningococcal disease.

Entities:  

Mesh:

Year:  1992        PMID: 1500737     DOI: 10.1093/infdis/166.3.542

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  29 in total

1.  Zanamivir, influenza, and meningococcal disease. Zanamivir may help to fight potential flu epidemic.

Authors:  S T Green
Journal:  BMJ       Date:  2000-02-05

2.  A 20-year ecological study of the temporal association between influenza and meningococcal disease.

Authors:  Elise Snitker Jensen; Søren Lundbye-Christensen; Susanne Samuelsson; Henrik Toft Sørensen; Henrik Carl Schønheyder
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

3.  Spatial dynamics of meningococcal meningitis in Niger: observed patterns in comparison with measles.

Authors:  N Bharti; H Broutin; R F Grais; M J Ferrari; A Djibo; A J Tatem; B T Grenfell
Journal:  Epidemiol Infect       Date:  2011-10-05       Impact factor: 2.451

Review 4.  The impact of successive infections on the lung microenvironment.

Authors:  Arnaud Didierlaurent; John Goulding; Tracy Hussell
Journal:  Immunology       Date:  2007-12       Impact factor: 7.397

5.  Systematic analysis of the relationship between antibiotic use and extended-spectrum beta-lactamase resistance in Enterobacteriaceae in a French hospital: a time series analysis.

Authors:  M-A Vibet; J Roux; E Montassier; S Corvec; M-E Juvin; C Ngohou; D Lepelletier; E Batard
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-07-24       Impact factor: 3.267

6.  Favorable outcome after life-threatening meningococcal disease complicating influenza A(H1N1) infection.

Authors:  S Legriel; S Merceron; P Tattevin; M-A Mouvier; S Marque-Juillet; A Le Monnier; J-P Bedos; F Bruneel
Journal:  Infection       Date:  2011-06-25       Impact factor: 3.553

7.  Risk factors for Neisseria meningitidis carriage in a school during a community outbreak of meningococcal infection.

Authors:  A L Davies; D O'Flanagan; R L Salmon; T J Coleman
Journal:  Epidemiol Infect       Date:  1996-10       Impact factor: 2.451

8.  First recorded outbreaks of meningococcal disease in the Israel Defence Force: three clusters due to serogroup C and the emergence of resistance to rifampicin.

Authors:  R Almog; C Block; M Gdalevich; B Lev; M Wiener; S Ashkenazi
Journal:  Infection       Date:  1994 Mar-Apr       Impact factor: 3.553

Review 9.  Mixed bacterial meningitis due to Streptococcus pneumoniae and Neisseria meningitidis in an 18-month-old child.

Authors:  H Marchandin; V Ventura; J-M Alonso; P Van de Perre
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

10.  Respiratory virus infection and risk of invasive meningococcal disease in central Ontario, Canada.

Authors:  Ashleigh R Tuite; Laura M Kinlin; Stefan P Kuster; Frances Jamieson; Jeffrey C Kwong; Allison McGeer; David N Fisman
Journal:  PLoS One       Date:  2010-11-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.